摘要
药物多晶型通常是指化学药物分子的不同排列方式,直接关系到药物的质量和疗效,也是药物领域专利审查、确权、诉讼等环节值得关注的焦点。本文基于两个药物多晶型领域专利案件在欧洲专利局的上诉过程,对欧洲专利局的药物多晶型创造性的评述思路进行分析,并进一步分析其对药物领域专利策略的影响。
Polymorph is pharmic compound molecules of different arrange form.It is directly referred to the quality and effect of pharmic compound, and it is the focus in examination, confirming the right and appeal.Basing on two pharmic compounds polymorph patent appeal cases of European Patent Office, the inventive step of polymorph recognized by European Patent Office, the influence of patent strategy in pharmacy field was expatiated.
出处
《中国发明与专利》
2017年第5期74-78,共5页
China Invention & Patent
关键词
药物
晶体
创造性
欧洲
专利
pharmic compound
polymorph
inventive step
Europe
patent
